Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Investments Regulatory News (EJFI)

Share Price Information for Ejf Investments (EJFI)

Share Price is delayed by 15 minutes
Get Live Data
130.00    0.00 (0.00%)
Bid:
126.00
Ask:
134.00
Spread: 8.00 (6.349%)
Market Cap: £75.51m
EJFI Live PriceLast checked at - London Stock Exchange

Intraday Ejf Investments Share Chart

Corporate Update

5 Mar 2020 09:25

RNS Number : 1313F
EJF Investments Ltd
05 March 2020
 

FOR IMMEDIATE RELEASE

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICITION WHERE IT IS UNLAWFUL TO DO SO

 

5 March 2020

EJF Investments Ltd

Corporate Update

 

The Board (the "Board") of EJF Investments Ltd (the "Company" or "EJFI") announces that it has been informed by the Company's investment manager, EJF Investments Manager LLC (the "Manager"), of certain forthcoming updates to the officers of the Manager and the Manager's investment committee, which is responsible for making investment decisions in relation to the Company.

 

From 5 March 2020, the officers of the Manager will comprise Neal J. Wilson (Chief Executive Officer), Peter Stage (Co-Chief Investment Officer, formerly Chief Financial Officer), Hammad Khan (Co-Chief Investment Officer, formerly Senior Managing Director, Europe) and Matthew Gill (Chief Financial Officer, formerly Accounting Director, Europe). All such individuals are existing officers of the Manager (although in certain cases, as noted above, in different capacities).

 

The Manager's investment committee will continue to consist of voting and non-voting members who are also employees of EJF Capital LLC and EJF Capital Ltd. (together, "EJF"). Voting members of the investment committee will continue to include Emanuel J. Friedman and Neal J. Wilson, and will be joined by Jason Ruggiero (Co-Chief Investment Officer and Senior Portfolio Manager of EJF) and Omer Ijaz (Senior Managing Director and Portfolio Manager of EJF) as new voting members, whilst Peter Stage and Hammad Khan will continue as non-voting members.

 

Emanuel J. Friedman will no longer act as Chairman and Co-Chief Investment Officer of the Manager but will continue as Co-Chief Executive Officer of EJF Capital LLC and in particular, as noted above, will continue to be a voting member of the investment committee of the Manager. Lindsay J. Sparacino (formerly Co-Chief Investment Officer of the Manager) is leaving EJF with the best wishes of the Board to pursue a new business opportunity in an unrelated sector (and which will not compete with the Company).

 

ENQUIRIES

 

For the Investment Manager

EJF Investments Manager LLC

Peter Stage / Hammad Khan / Matthew Gill

pstage@ejfcap.com / hkhan@ejfcap.com / mgill@ejfcap.com

+44 203 752 6775 / +44 203 752 6771 / +44 203 752 6774

 

For the Company Secretary and Administrator

BNP Paribas Securities Services S.C.A

jersey.bp2s.ejf.cosec@bnpparibas.com

+44 1534 709181 / +44 1534 813996

 

For the Broker

Numis Securities Limited

David Luck

d.luck@numis.com

+44 20 7260 1301

About EJF Investments Ltd

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

The JFSC has not reviewed or approved this announcement.

LEI: 549300XZYEQCLA1ZAT25

Investor information & warnings

The latest available information on the Company can be accessed via its website at www.ejfi.com.

 

This communication has been issued by, and is the sole responsibility of, the Company and is for information purposes only. It is not, and is not intended to be an invitation, inducement, offer or solicitation to deal in the shares of the Company. The price and value of shares in the Company and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of shares in the Company. An investment in the Company should be considered only as part of a balanced portfolio of which it should not form a disproportionate part. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKELBBBXLLBBL
Date   Source Headline
14th May 20247:00 amRNSQUARTERLY REPORT
2nd May 20245:00 pmRNSDividend Declaration
2nd May 20247:00 amRNSDirectorate Change
30th Apr 20249:33 amRNSPortfolio Update
22nd Apr 20247:00 amRNSNet Asset Value and Portfolio Update
28th Mar 20247:00 amRNSAnnual Financial Report to 31 December 2023
21st Mar 20247:00 amRNSNet Asset Value and Portfolio Update
15th Mar 202410:40 amRNSResults Presentation for the YE 31 December 2023
21st Feb 20247:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
31st Jan 20243:00 pmRNSQUARTERLY REPORT
29th Jan 20244:57 pmRNSDividend Declaration - Replacement
29th Jan 20247:00 amRNSDividend Declaration
22nd Jan 20247:00 amRNSNet Asset Value and Portfolio Update
22nd Dec 20237:00 amRNSCorporate Update
20th Dec 20237:00 amRNSNet Asset Value and Portfolio Update
21st Nov 20237:00 amRNSNet Asset Value and Portfolio Update
2nd Nov 202310:43 amRNSQUARTERLY REPORT
25th Oct 20237:00 amRNSDividend Declaration
20th Oct 20237:00 amRNSNet Asset Value(s)
21st Sep 20237:00 amRNSNet Asset Value and Portfolio Update
8th Sep 20237:00 amRNSHalf-year Report
25th Aug 20234:32 pmRNSUpdate to composition of the Board of Directors
23rd Aug 20232:42 pmRNSNotice of Interim Results and Results Presentation
21st Aug 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
1st Aug 20237:00 amRNSQUARTERLY REPORT
27th Jul 20235:34 pmRNSDividend Declaration
27th Jul 20237:00 amRNSPortfolio Update
20th Jul 20237:00 amRNSNet Asset Value and Portfolio Update
21st Jun 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
21st Jun 20237:00 amRNSCORPORATE UPDATE
13th Jun 20234:07 pmRNSResult of AGM
25th May 20239:14 amRNSQuarterly Report
24th May 20237:00 amRNSNet Asset Value and Portfolio Update
18th May 20235:22 pmRNSNotice of AGM
26th Apr 20233:13 pmRNSDividend Declaration
25th Apr 20235:12 pmRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
31st Mar 20237:00 amRNSAnnual Financial Report to 31 December 2022
29th Mar 20237:00 amRNSPortfolio Update
21st Mar 20237:00 amRNSNet Asset Value(s)
15th Mar 20237:00 amRNSPortfolio Update
27th Feb 20237:00 amRNSResults of Placing
21st Feb 20237:00 amRNSNet Asset Value(s)
20th Feb 20237:00 amRNSIssue of 2025 ZDP Shares under Placing Programme
26th Jan 20235:07 pmRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
11th Jan 20232:10 pmRNSCorporate Update
21st Dec 20227:00 amRNSNet Asset Value(s)
21st Nov 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.